Literature DB >> 17099727

Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.

J Xu1, M Gao, S Fan, Q Meng, I D Goldberg, R Abounader, H Ressom, J J Laterra, E M Rosen.   

Abstract

The cytokine scatter factor (SF) (hepatocyte growth factor) transduces various biologic actions, including cell motility, invasion, angiogenesis and apoptosis inhibition. The latter is relevant to understanding the role of SF in promoting tumor cell survival in different contexts, for example, detachment from basement membrane, growth in metastatic sites and responses to chemo- and radiotherapy. Previously, we showed that SF protects cells against apoptosis owing to DNA damage, by a mechanism involving phosphoinositol-3-kinase/c-Akt signaling. Here, we used DNA microarray assays to identify c-Akt-regulated genes that might contribute to cell protection. DU-145 human prostate cancer cells were transfected+/-a dominant-negative mutant Akt, treated+/-SF and analysed for gene expression using Affymetrix arrays. These studies identified SF-regulated genes for which induction was c-Akt-dependent vs -independent. Selected microarray findings were confirmed by semiquantitative and quantitative reverse transcription-polymerase chain reaction. We tested the contribution of four SF-inducible/c-Akt-dependent genes (AMPD3, EPHB2, MX1 and WNT4) to protection against adriamycin (a DNA topoisomerase IIalpha inhibitor) using RNA interference. Knockdown of each gene except EPHB2 caused a small but significant reduction in the SF cell protection. The lack of effect of EPHB2 knockdown may be due to the fact that DU-145 cells contain a single-mutant EPHB2 allele. A combination of three small interfering RNAs blocked most of the protection by SF in both DU-145 and T47D cells. These findings identify novel c-Akt-regulated genes, some of which contribute to SF-mediated cytoprotection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099727     DOI: 10.1038/sj.onc.1210088

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer.

Authors:  Hua Zhang; Nicos Angelopoulos; Yichen Xu; Arnhild Grothey; Joao Nunes; Justin Stebbing; Georgios Giamas
Journal:  Breast Cancer Res Treat       Date:  2015-05-29       Impact factor: 4.872

2.  Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis.

Authors:  Pang-Kuo Lo; Yongshu Zhang; Benjamin Wolfson; Ramkishore Gernapudi; Yuan Yao; Nadire Duru; Qun Zhou
Journal:  Oncotarget       Date:  2016-10-04

3.  Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.

Authors:  Yang Li; Xing Fan; C Rory Goodwin; John Laterra; Shuli Xia
Journal:  BMC Cancer       Date:  2008-11-07       Impact factor: 4.430

4.  Functional non-coding polymorphism in an EPHA2 promoter PAX2 binding site modifies expression and alters the MAPK and AKT pathways.

Authors:  Xiaoyin Ma; Zhiwei Ma; Xiaodong Jiao; J Fielding Hejtmancik
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.